Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 251

1.

Increasing HDL levels by inhibiting cholesteryl ester transfer protein activity in rabbits with hindlimb ischemia is associated with increased angiogenesis.

Wu BJ, Shrestha S, Ong KL, Johns D, Dunn LL, Hou L, Barter PJ, Rye KA.

Int J Cardiol. 2015 Jul 11;199:204-212. doi: 10.1016/j.ijcard.2015.07.014. [Epub ahead of print]

PMID:
26204569
2.

Relationship of pericardial fat with lipoprotein distribution: The Multi-Ethnic study of atherosclerosis.

Ong KL, Ding J, McClelland RL, Cheung BM, Criqui MH, Barter PJ, Rye KA, Allison MA.

Atherosclerosis. 2015 Aug;241(2):664-70. doi: 10.1016/j.atherosclerosis.2015.06.027. Epub 2015 Jun 18.

PMID:
26117404
3.

To what extent do high-intensity statins reduce low-density lipoprotein cholesterol in each of the four statin benefit groups identified by the 2013 American College of Cardiology/American Heart Association guidelines? A VOYAGER meta-analysis.

Karlson BW, Palmer MK, Nicholls SJ, Lundman P, Barter PJ.

Atherosclerosis. 2015 Aug;241(2):450-4. doi: 10.1016/j.atherosclerosis.2015.05.029. Epub 2015 Jun 3.

PMID:
26074319
4.

Relationship of fibroblast growth factor 21 with baseline and new on-study microvascular disease in the Fenofibrate Intervention and Event Lowering in Diabetes study.

Ong KL, Januszewski AS, O'Connell R, Buizen L, Jenkins AJ, Xu A, Sullivan DR, Barter PJ, Scott RS, Taskinen MR, Rye KA, Keech AC; FIELD study investigators.

Diabetologia. 2015 Jun 9. [Epub ahead of print]

PMID:
26055067
5.

Cholesterol ester transfer protein inhibition by TA-8995 in patients with mild dyslipidaemia (TULIP): a randomised, double-blind, placebo-controlled phase 2 trial.

Hovingh GK, Kastelein JJ, van Deventer SJ, Round P, Ford J, Saleheen D, Rader DJ, Brewer HB, Barter PJ.

Lancet. 2015 Jun 2. pii: S0140-6736(15)60158-1. doi: 10.1016/S0140-6736(15)60158-1. [Epub ahead of print]

PMID:
26047975
6.

Relationship of pericardial fat with biomarkers of inflammation and hemostasis, and cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis.

Ong KL, Ding J, McClelland RL, Cheung BM, Criqui MH, Barter PJ, Rye KA, Allison MA.

Atherosclerosis. 2015 Apr;239(2):386-92. doi: 10.1016/j.atherosclerosis.2015.01.033. Epub 2015 Jan 31.

PMID:
25682037
7.

Cholesteryl ester transfer protein inhibition enhances endothelial repair and improves endothelial function in the rabbit.

Wu BJ, Shrestha S, Ong KL, Johns D, Hou L, Barter PJ, Rye KA.

Arterioscler Thromb Vasc Biol. 2015 Mar;35(3):628-36. doi: 10.1161/ATVBAHA.114.304747. Epub 2015 Jan 29.

PMID:
25633313
8.

The relationship of fibroblast growth factor 21 with cardiovascular outcome events in the Fenofibrate Intervention and Event Lowering in Diabetes study.

Ong KL, Januszewski AS, O'Connell R, Jenkins AJ, Xu A, Sullivan DR, Barter PJ, Hung WT, Scott RS, Taskinen MR, Keech AC, Rye KA.

Diabetologia. 2015 Mar;58(3):464-73. doi: 10.1007/s00125-014-3458-7. Epub 2014 Nov 26.

PMID:
25425220
9.

Sex-related differences of coronary atherosclerosis regression following maximally intensive statin therapy: insights from SATURN.

Puri R, Nissen SE, Shao M, Ballantyne CM, Barter PJ, Chapman MJ, Erbel R, Libby P, Raichlen JS, Uno K, Kataoka Y, Nicholls SJ.

JACC Cardiovasc Imaging. 2014 Oct;7(10):1013-22. doi: 10.1016/j.jcmg.2014.04.019. Epub 2014 Sep 17.

PMID:
25240453
10.

Antiatherosclerotic effects of long-term maximally intensive statin therapy after acute coronary syndrome: insights from Study of Coronary Atheroma by Intravascular Ultrasound: Effect of Rosuvastatin Versus Atorvastatin.

Puri R, Nissen SE, Shao M, Ballantyne CM, Barter PJ, Chapman MJ, Erbel R, Libby P, Raichlen JS, Uno K, Kataoka Y, Nicholls SJ.

Arterioscler Thromb Vasc Biol. 2014 Nov;34(11):2465-72. doi: 10.1161/ATVBAHA.114.303932. Epub 2014 Sep 11.

PMID:
25212234
11.

High-intensity statin therapy alters the natural history of diabetic coronary atherosclerosis: insights from SATURN.

Stegman B, Puri R, Cho L, Shao M, Ballantyne CM, Barter PJ, Chapman MJ, Erbel R, Libby P, Raichlen JS, Uno K, Kataoka Y, Nissen SE, Nicholls SJ.

Diabetes Care. 2014 Nov;37(11):3114-20. doi: 10.2337/dc14-1121. Epub 2014 Sep 4.

PMID:
25190674
12.

Apolipoprotein A-I increases insulin secretion and production from pancreatic β-cells via a G-protein-cAMP-PKA-FoxO1-dependent mechanism.

Cochran BJ, Bisoendial RJ, Hou L, Glaros EN, Rossy J, Thomas SR, Barter PJ, Rye KA.

Arterioscler Thromb Vasc Biol. 2014 Oct;34(10):2261-7. doi: 10.1161/ATVBAHA.114.304131. Epub 2014 Aug 21.

PMID:
25147338
13.

The relationship between insulin resistance and vascular calcification in coronary arteries, and the thoracic and abdominal aorta: the Multi-Ethnic Study of Atherosclerosis.

Ong KL, McClelland RL, Rye KA, Cheung BM, Post WS, Vaidya D, Criqui MH, Cushman M, Barter PJ, Allison MA.

Atherosclerosis. 2014 Oct;236(2):257-62. doi: 10.1016/j.atherosclerosis.2014.07.015. Epub 2014 Jul 27.

PMID:
25108074
14.

The relationship between total bilirubin levels and total mortality in older adults: the United States National Health and Nutrition Examination Survey (NHANES) 1999-2004.

Ong KL, Allison MA, Cheung BM, Wu BJ, Barter PJ, Rye KA.

PLoS One. 2014 Apr 11;9(4):e94479. doi: 10.1371/journal.pone.0094479. eCollection 2014.

15.

Effect of change in body weight on incident diabetes mellitus in patients with stable coronary artery disease treated with atorvastatin (from the treating to new targets study).

Ong KL, Waters DD, Messig M, DeMicco DA, Rye KA, Barter PJ.

Am J Cardiol. 2014 May 15;113(10):1593-8. doi: 10.1016/j.amjcard.2014.02.011. Epub 2014 Mar 1. Erratum in: Am J Cardiol. 2015 May 1;115(9):1323.

PMID:
24666618
16.

Cardiovascular drugs that increase the risk of new-onset diabetes.

Ong KL, Barter PJ, Waters DD.

Am Heart J. 2014 Apr;167(4):421-8. doi: 10.1016/j.ahj.2013.12.025. Epub 2014 Jan 14. Review.

PMID:
24655688
17.

Elevated plasma PCSK9 level is equally detrimental for patients with nonfamilial hypercholesterolemia and heterozygous familial hypercholesterolemia, irrespective of low-density lipoprotein receptor defects.

Lambert G, Petrides F, Chatelais M, Blom DJ, Choque B, Tabet F, Wong G, Rye KA, Hooper AJ, Burnett JR, Barter PJ, Marais AD.

J Am Coll Cardiol. 2014 Jun 10;63(22):2365-73. doi: 10.1016/j.jacc.2014.02.538. Epub 2014 Mar 12.

18.

HDL-transferred microRNA-223 regulates ICAM-1 expression in endothelial cells.

Tabet F, Vickers KC, Cuesta Torres LF, Wiese CB, Shoucri BM, Lambert G, Catherinet C, Prado-Lourenco L, Levin MG, Thacker S, Sethupathy P, Barter PJ, Remaley AT, Rye KA.

Nat Commun. 2014 Feb 28;5:3292. doi: 10.1038/ncomms4292.

19.

Long-term effects of maximally intensive statin therapy on changes in coronary atheroma composition: insights from SATURN.

Puri R, Libby P, Nissen SE, Wolski K, Ballantyne CM, Barter PJ, Chapman MJ, Erbel R, Raichlen JS, Uno K, Kataoka Y, Tuzcu EM, Nicholls SJ.

Eur Heart J Cardiovasc Imaging. 2014 Apr;15(4):380-8. doi: 10.1093/ehjci/jet251. Epub 2014 Jan 20.

PMID:
24448227
20.

High density lipoprotein: a therapeutic target in type 2 diabetes.

Barter PJ.

Endocrinol Metab (Seoul). 2013 Sep;28(3):169-77. doi: 10.3803/EnM.2013.28.3.169. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk